IR@PKUHSC  > 北京大学深圳医院  > 病理科
学科主题临床医学
Nuclear matrix associated protein PML: an arsenic trioxide apoptosis therapeutic target protein in HepG2 cells
Yu, D; Wang, ZH; Zhu, LY; Ec, C
关键词nuclear matrix arsenic trioxide PML protein apoptosis HepG2 cell line
刊名CHINESE MEDICAL JOURNAL
2003
116期:1页:93-98
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Medicine, General & Internal
研究领域[WOS]General & Internal Medicine
关键词[WOS]ACUTE PROMYELOCYTIC LEUKEMIA ; ESOPHAGEAL-CARCINOMA CELLS ; IN-VITRO ; GROWTH-INHIBITION ; RETINOIC ACID ; CANCER CELLS ; EXPRESSION ; CYTOTOXICITY ; ALPHA ; AS2O3
英文摘要

Objective To investigate arsenic trioxide (As2O3)-induced apoptosis and the effects on cell nuclear matrix related protein promyelocytic leukaemia (PML).

Methods HepG2 cells were cultured in MEM medium and treated with 0.5, 2, 5 and 10 mumol/L As2O3 for either 24 h or 96 h at each concentration. In situ terminal deoxynucleotidyl transferase (TdT) labeling (TUNEL) and DNA ladders were used to detect apoptosis. Confocal microscopy and Western blotting were used to observe the expression of PML.

Results The growth rates of HepG2 cells were slower in the As2O3 treated than the untreated control group. DNA ladder and TUNEL positive apoptotic cells could be detected in As2O3 treated groups. The expression of PML decreased in HepG2 cells with 2 mumol/L As2O3 treatment. Confocal images demonstrated that the expression, of PML protein in HepG2 cell nuclei decreased after treatment with 2 mumol/L As2O3, and micropunctates characteristic of PML protein in HepG2 cell nuclei disappeared after treatment with 5 mumol/L As2O3.

Conclusions Our results show that arsenic trioxide can significantly inhibit the growth of HepG2 cells in vitro. As2O3 induces apoptosis in HepG2 tumor cells in a time and concentration dependent manner. As2O3 may degrade the PML protein in HepG2 cell nuclei. The decreased expression of PML in As2O3 treated tumor cells is most likely to be caused by apoptosis. Nuclear matrix associated protein PML could be the target of As2O3 therapy.

语种英语
WOS记录号WOS:000181239800021
引用统计
被引频次:6[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/66299
专题北京大学深圳医院_病理科
作者单位1.Beijing Univ, Shenzhen Hosp, Dept Pathol, Shenzhen 518036, Peoples R China
2.Beijing Univ, Shenzhen Hosp, Dept Surg, Shenzhen 518036, Peoples R China
3.Chinese Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China
推荐引用方式
GB/T 7714
Yu, D,Wang, ZH,Zhu, LY,et al. Nuclear matrix associated protein PML: an arsenic trioxide apoptosis therapeutic target protein in HepG2 cells[J]. CHINESE MEDICAL JOURNAL,2003,116(1):93-98.
APA Yu, D,Wang, ZH,Zhu, LY,&Ec, C.(2003).Nuclear matrix associated protein PML: an arsenic trioxide apoptosis therapeutic target protein in HepG2 cells.CHINESE MEDICAL JOURNAL,116(1),93-98.
MLA Yu, D,et al."Nuclear matrix associated protein PML: an arsenic trioxide apoptosis therapeutic target protein in HepG2 cells".CHINESE MEDICAL JOURNAL 116.1(2003):93-98.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Yu, D]的文章
[Wang, ZH]的文章
[Zhu, LY]的文章
百度学术
百度学术中相似的文章
[Yu, D]的文章
[Wang, ZH]的文章
[Zhu, LY]的文章
必应学术
必应学术中相似的文章
[Yu, D]的文章
[Wang, ZH]的文章
[Zhu, LY]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。